Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Fetal Bovine Serum, Adult Bovine Serum, Porcine Serum, Horse Serum, and Other Animal Serum); By Application (Bioproduction, Drug Discovery, Tissue Engineering and Regenerative Medicines, Toxicity Testing, and Academic Research); and Geography
Publication Month: Nov 2020 | Report Code: TIPRE00015863 | No. of Pages: 164 | Category: Biotechnology | Status: Published
The cell line development serum market is expected to reach US$ 1,467.92 million by 2027 from US$ 915.58 million in 2019. The market is estimated to grow with a CAGR of 6.1% from 2020 to 2027.
Regenerative medicines have the potential to replace or heal tissues, as well as organs, and normalize congenital defects. Certain age-related abnormalities, diseases, and trauma damage the tissues and organs. Over the last decade of a century, the tissue engineering industry has emerged impressively, and it has now evolved into the broader area of regenerative medicine, which focuses on the development of clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. Thus, advancements in the regenerative medicine boost the demand for serum used in cell line development.
Cell lines play a major role in testing and development of drugs, development of cell-based therapy, and research related to cancer tissues, among other applications. New drugs developed in pharmaceutical companies are safely and effectively tested on differentiated stem cells for checking their potential. Further, the regenerative medicines using cell-based models have the potential to help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries. Thus, surge in the use of regenerative medicines propels the cell line development serum market
Lucrative Regional Markets for Cell Line Development Serum
Get more information on this report :
Market Insights
Increasing Adoption of Regenerative Medicines
Regenerative medicines have the potential to replace or heal tissues, as well as organs, and normalize congenital defects. Certain age-related abnormalities, diseases, and trauma damage the tissues and organs. Over the last decade of a century, the tissue engineering industry has emerged impressively, and it has now evolved into the broader area of regenerative medicine, which focuses on the development of clinical therapies for the maintenance, repair, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. Thus, advancements in the regenerative medicine boost the demand for serum used in cell line development.
Cell lines are instrumental in testing and development of drugs, development of cell-based therapy, and research related to cancer tissues, among other applications. New drugs developed in pharmaceutical companies are safely and effectively tested on differentiated stem cells for checking their potential. Further, the regenerative medicines using cell-based models have the potential to help the researchers in early-intervention treatment for degenerative diseases and traumatic injuries. Thus, surge in the use of regenerative medicines propels the cell line development serum market.
Type Insights
Based on type, the cell line development serum market is segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, and other animal serum. In 2019, the fetal bovine serum segment accounted for the largest share of the market. Growth of this segment is attributed to increase in blood tests, urine tests, and different imaging procedures.
Global Cell Line Development Serum Market, by Type– 2019 and 2027
Get more information on this report :
End User Insights
Based on application, the global cell line development serum market is segmented into tissue engineering and regenerative medicines, toxicity testing, research, drug discovery, bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.
Strategic Insights
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios to meet the growing consumer demand. The cell line development serum market players adopt the collaborations strategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Cell Line Development Serum Market – By Type
- Fetal Bovine Serum
- Adult Bovine Serum
- Porcine Serum
- Horse Serum
- Other Animal Serum
Cell Line Development Serum Market – By Application
- Bioproduction
- Drug Discovery
- Tissue Engineering and Regenerative Medicines
- Toxicity Testing
- Academic Research
Cell Line Development Serum Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Lonza
- Thermo Fisher Scientific Inc.
- Sigma-Aldrich Corporation (Merck KGaA)
- (Cytiva) Danaher
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC) Group
Frequently Asked Questions
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development serum market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550 $3640
-
$6550 $5240
-
$8550 $6840
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount